Earnings estimate | Current qtr. (Jun 2022) | Next qtr. (Sep 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
No. of analysts | 1 | 1 | 3 | 3 |
Avg. Estimate | 0.71 | 0.83 | 3.24 | 3.5 |
Low estimate | 0.71 | 0.83 | 3.05 | 3.32 |
High estimate | 0.71 | 0.83 | 3.36 | 3.62 |
Year ago EPS | 0.79 | 1.01 | 3.11 | 3.24 |
Revenue estimate | Current qtr. (Jun 2022) | Next qtr. (Sep 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
No. of analysts | 2 | 2 | 3 | 3 |
Avg. Estimate | 10.8B | 11.84B | 45.31B | 46.28B |
Low estimate | 10.6B | 11.83B | 45.15B | 44.97B |
High estimate | 11.01B | 11.86B | 45.6B | 47.09B |
Year ago sales | 11.31B | N/A | 46.91B | 45.31B |
Sales growth (year/est) | -4.50% | N/A | -3.40% | 2.10% |
Earnings history | 29/06/2021 | 29/09/2021 | 30/12/2021 | 30/03/2022 |
---|---|---|---|---|
Est. EPS | 0.51 | 0.81 | 0.65 | 0.74 |
Actual EPS | 0.79 | 1.01 | 0.69 | 0.87 |
Difference | 0.28 | 0.2 | 0.04 | 0.13 |
Surprise % | 54.90% | 24.70% | 6.20% | 17.60% |
EPS trend | Current qtr. (Jun 2022) | Next qtr. (Sep 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
Current estimate | 0.71 | 0.83 | 3.24 | 3.5 |
7 days ago | 0.71 | 0.83 | 3.24 | 3.5 |
30 days ago | 0.71 | 0.83 | 3.32 | 3.55 |
60 days ago | 0.73 | 0.86 | 3.28 | 3.52 |
90 days ago | 0.69 | 0.82 | 3.28 | 3.48 |
EPS revisions | Current qtr. (Jun 2022) | Next qtr. (Sep 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | 1 | 1 |
Up last 30 days | 1 | 1 | 1 | 2 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | GSK | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | -10.10% | N/A | N/A | N/A |
Next qtr. | -17.80% | N/A | N/A | N/A |
Current year | 4.20% | N/A | N/A | N/A |
Next year | 8.00% | N/A | N/A | N/A |
Next 5 years (per annum) | 8.20% | N/A | N/A | N/A |
Past 5 years (per annum) | 4.75% | N/A | N/A | N/A |